Goran Hauser
Goran Hauser
Docent na Katedri za internu medicinu Medicinskog fakulteta Rijeka
Verified email at medri.uniri.hr
TitleCited byYear
Peginterferon alpha‐2a is associated with higher sustained virological response than peginterferon alfa‐2b in chronic hepatitis C: systematic review of randomized trials
T Awad, K Thorlund, G Hauser, D Stimac, M Mabrouk, C Gluud
Hepatology 51 (4), 1176-1184, 2010
2052010
Direct‐acting antivirals for chronic hepatitis C
JC Jakobsen, EE Nielsen, J Feinberg, KK Katakam, K Fobian, G Hauser, ...
Cochrane Database of Systematic Reviews, 2017
1472017
Transient elastography (FibroScan«) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver diseaseá…
I Mikolasevic, L Orlic, N Franjic, G Hauser, D Stimac, S Milic
World journal of gastroenterology 22 (32), 7236, 2016
872016
Nonalcoholic fatty liver disease-A multisystem disease?
I Mikolasevic, S Milic, TT Wensveen, I Grgic, I Jakopcic, D Stimac, ...
World journal of gastroenterology 22 (43), 9488, 2016
742016
Enteral nutrition formulations for acute pancreatitis
G Poropat, V Giljaca, G Hauser, D Štimac
Cochrane Database of Systematic Reviews, 2015
632015
Minimally invasive treatment of pancreatic pseudocysts
E Zerem, G Hauser, S Loga-Zec, S Kunosić, P Jovanović, D Crnkić
World Journal of Gastroenterology: WJG 21 (22), 6850, 2015
582015
FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis
NN Salkic, P Jovanovic, G Hauser, M Brcic
American Journal of Gastroenterology 109 (6), 796-809, 2014
562014
Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial
G Hauser, N Salkic, K Vukelic, A JajacKnez, D Stimac
Medicine 94 (17), 2015
532015
Differences in the health-related quality of life, affective status, and personality between irritable bowel syndrome and inflammatory bowel disease patients
M Tkalcic, G Hauser, D Štimac
European journal of gastroenterology & hepatology 22 (7), 862-867, 2010
502010
Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C
G Hauser, T Awad, J Brok, K Thorlund, D Štimac, M Mabrouk, C Gluud, ...
Cochrane Database of Systematic Reviews, 2014
402014
Gender related differences in quality of life and affective status in patients with inflammatory bowel disease
G Hauser, M Tkalčić, D Štimac, S Milić, B Mijandrušić Sinčić
Collegium antropologicum 35 (2), 203-207, 2011
382011
Cognitive behavioral approach to understanding irritable bowel syndrome
G Hauser, S Pletikosic, M Tkalcic
World J Gastroenterol 20 (22), 6744-6758, 2014
332014
Early nasojejunal tube feeding versus nil-by-mouth in acute pancreatitis: a randomized clinical trial
D Stimac, G Poropat, G Hauser, V Licul, N Franjic, PV Zujic, S Milic
Pancreatology 16 (4), 523-528, 2016
292016
Diagnosis of irritable bowel syndrome: role of potential biomarkers
I Plavšić, G Hauser, M Tkalčić, S Pletikosić, N Salkić
Gastroenterology research and practice 2015, 2015
262015
Preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: What can be done?
G Hauser, M Milosevic, D Stimac, E Zerem, P Jovanović, I Blazevic
World journal of gastroenterology: WJG 21 (4), 1069, 2015
252015
Clinical utility of red cell distribution width in alcoholic and non-alcoholic liver cirrhosis
S Milić, I Mikolašević, M Radić, G Hauser, D Štimac
Collegium antropologicum 35 (2), 335-338, 2011
232011
Peginterferon alpha‐2a versus peginterferon alpha‐2b for chronic hepatitis C
G Hauser, T Awad, K Thorlund, D Štimac, M Mabrouk, C Gluud
status and date: New, published in, 2014
202014
Erythrocyte sedimentation rate–possible role in determining the existence of the low grade inflammation in irritable bowel syndrome patients
G Hauser, M Tkalcic, S Pletikosic, N Grabar, D Stimac
Medical hypotheses 78 (6), 818-820, 2012
182012
Attentional biases in irritable bowel syndrome patients
M Tkalcic, D Domijan, S Pletikosic, M Setic, G Hauser
Clinics and research in hepatology and gastroenterology 38 (5), 621-628, 2014
162014
Proceed with caution peginterferon alpha-2a versus peginterferon alfa-2b in chronic hepatitis C. A systematic review of randomized trials reply
T Awad, K Thorlund, G Hauser, D Štimac, M Marbrouk, C Gluud
Hepatology (Baltimore, Md.) 52 (6), 2241, 2010
162010
The system can't perform the operation now. Try again later.
Articles 1–20